BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Experts in dermatology, medical aesthetics, tissue engineering - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Experts in dermatology, medical aesthetics, tissue engineering
X-ORIGINAL-URL:https://www.rbcconsultants.com
X-WR-CALDESC:Events for Experts in dermatology, medical aesthetics, tissue engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260624T190000
DTEND;TZID=America/New_York:20260624T200000
DTSTAMP:20260620T171958
CREATED:20260611T192916Z
LAST-MODIFIED:20260611T193049Z
UID:1677-1782327600-1782331200@www.rbcconsultants.com
SUMMARY:EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients?
DESCRIPTION:Speaker: Sam Awan\, MD\, FAAD Board-certified Dermatologist U.S. Dermatology Partners McKinney\, Texas Baylor Scott & White Health Southwestern Health Resources \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients? Join your colleagues for a peer discussion exploring the latest EBGLYSS data. This program is sponsored by\, and the speaker is presenting on behalf of\, Lilly USA\, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for Use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company\, its subsidiaries\, or affiliates. \n  \nREGISTER
URL:https://www.rbcconsultants.com/event/ebglysslebrikizumab-lbkz-what-could-less-mean-for-your-patients/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260625T200000
DTEND;TZID=America/New_York:20260625T210000
DTSTAMP:20260620T171958
CREATED:20260603T120406Z
LAST-MODIFIED:20260603T120406Z
UID:1672-1782417600-1782421200@www.rbcconsultants.com
SUMMARY:The Science of Hyaluronic Acid\, Skin Volumization\, and Regenerative Topical Innovation
DESCRIPTION:Speaker: Shino Bay\, DO Board-Certified Dermatologist Founder\, Owner\, and Medical Director Shino Bay Cosmetic Dermatology & Laser Institute Fort Lauderdale\, Florida \nModerator: Roxane Chabot President RBC Consultants \nPlease join us for our next RBC Consultants Educational Series Webinar: Beyond Hydration: The Science of Hyaluronic Acid\, Skin Volumization\, and Regenerative Topical Innovation Join Shino Bay\, DO\, internationally recognized dermatologist\, cosmetic dermatologic surgeon\, and educator\, for an in-depth exploration of the evolving science of hyaluronic acid in skin aging\, structural integrity\, and facial rejuvenation. This presentation will examine the biological role of hyaluronic acid beyond hydration\, including its influence on dermal architecture\, extracellular matrix signaling\, and age-related volume loss. Dr. Bay will review emerging advances in topical HA technology\, including novel conjugated hyaluronic acid platforms designed to enhance stability\, penetration\, biomarker activation\, and visible skin volumization. Clinical\, histologic\, and instrumental study findings will be discussed\, highlighting outcomes in plumpness\, contour\, skin quality\, hydration\, and barrier function. Attendees will gain practical insight into the future of regenerative topical skincare and evidence-based approaches for addressing visible signs of skin aging and structural volume loss. \nREGISTER
URL:https://www.rbcconsultants.com/event/the-science-of-hyaluronic-acid-skin-volumization-and-regenerative-topical-innovation/
END:VEVENT
END:VCALENDAR